Percutaneous coronary intervention for acute coronary syndromes: no difference in 30-day efficacy or safety of high- and low-dose aspirin; double-dose clopidogrel reduces 30-day risk of cardiovascular death, myocardial infarction or stroke compared with standard dose but increases risk of major bleeding
Lala, A.; Berger, J.S.
Evidence-Based Medicine 16(3): 80-81
2011
ISSN/ISBN: 1473-6810 PMID: 21300632 DOI: 10.1136/ebm1187Document Number: 250080
Document emailed within 0-6 h
Related Documents
Ren, L.-h.; Peng, J.-j.; Ye, H.-m.; Wang, Z.-y.; Chen, C. 2012: High-dose tirofiban in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Zhonghua Yi Xue Za Zhi 92(28): 1981-1983Tsukahara, K.; Kimura, K.; Usui, T.; Okuda, J.; Kitamura, Y.; Kosuge, M.; Sano, T.; Tohyama, S.; Nemoto, T.; Yamanaka, O.; Yoshii, Y.; Tochikubo, O.; Umemura, S. 2001: Efficacy of low-dose mutant tissue-type plasminogen activator followed by planned rescue percutaneous transluminal coronary angioplasty as reperfusion therapy for acute myocardial infarction Journal of Cardiology 37(3): 143-150
Iga, A.; Wagatsuma, K.; Yamazaki, J.; Ikeda, T. 2014: Transradial versus transfemoral coronary intervention for acute myocardial infarction complicated by cardiogenic shock: is transradial coronary intervention suitable for emergency PCi in high-risk acute myocardial infarction? Journal of Invasive Cardiology 26(5): 196-202
Gum, P.A.; Lincoff, A.M. 2003: Abciximab and atherosclerotic heart disease: use in percutaneous coronary intervention, acute coronary syndromes and acute myocardial infarction International Journal of Clinical Practice 57(1): 43-48
Bagai, J.; Webb, D.; Kasasbeh, E.; Crenshaw, M.; Salloum, J.; Chen, J.; Zhao, D. 2011: Efficacy and safety of percutaneous life support during high-risk percutaneous coronary intervention, refractory cardiogenic shock and in-laboratory cardiopulmonary arrest Journal of Invasive Cardiology 23(4): 141-147
Brener, S.J.; Alapati, V.; Benson, M.M.; Chan, D.; Cunn, G.; Khan, S.; Kutkut, I.; Narayanan, C.Arun.; O'Laughlin, J.P.; Sacchi, T.J. 2019: Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Insights From a Single Institution Registry Journal of Invasive Cardiology 31(8): 235-238
Chevallier, B. 1990: Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. the Granisetron Study Group European Journal of Cancer 26(Suppl 1): S33-S36
Seth, A.; Sinha, N.; Parikh, K.; Patel, T.; Hiremath, M.S.; Mehta, A.B.; Chandra, P.; Pinto, B.; Sethi, K.K.; Sengottuvelu, S. 2008: Safety and efficacy of indigenously developed and manufactured bivalirudin in moderate/high-risk Indian patients undergoing percutaneous coronary intervention: the Bivaflo Registry Indian Heart Journal 60(4): 333-341
Rattanasupar, A.; Sengmanee, S. 2016: Comparison of High Dose and Standard Dose Proton Pump Inhibitor before Endoscopy in Patients with Non-Portal Hypertension Bleeding Journal of the Medical Association of Thailand 99(9): 988-995
Moreira, A.E.; Esteves Filho, A.; Ferreira, S.M.; Ariê, S.; Tranchesi Júnior, B. 1996: High risk percutaneous transluminal coronary angioplasty after mechanical recanalization of the unprotected left main stem coronary artery and during myocardial infarction Arquivos Brasileiros de Cardiologia 66(2): 75-78
Simonsen, P.E.; Meyrowitsch, D.W.; Makunde, W.H.; Magnussen, P. 1995: Selective diethylcarbamazine chemotherapy for control of Bancroftian filariasis in two communities of Tanzania: compared efficacy of a standard dose treatment and two semi-annual single dose treatments American Journal of Tropical Medicine and Hygiene 53(3): 267-272
Fu, Y.; Li, K.; Yang, X. 2015: Safety of percutaneous coronary intervention in patients with acute coronary syndromes complicating chronic kidney disease Zhonghua Xin Xue Guan Bing Za Zhi 43(10): 848-853
Jayedi, A.; Zargar, M.S.; Shab-Bidar, S. 2019: Fish consumption and risk of myocardial infarction: a systematic review and dose-response meta-analysis suggests a regional difference Nutrition Research 62: 1-12
Li, W.-m.; Li, Y.; Zhao, J.-y.; Duan, Y.-n.; Sheng, L.; Yang, B.-f.; Wang, F.-l.; Gong, Y.-t.; Yang, S.-s.; Zhou, L.-j.; Liu, P.-d.; Zhang, L.; Chu, S. 2007: Safety and feasibility of emergent percutaneous coronary intervention with the transradial access in patients with acute myocardial infarction Chinese Medical Journal 120(7): 598-600
Akkasilpa, S.; Osiri, M.; Deesomchok, U.; Avihingsanon, Y. 2004: The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia Journal of the Medical Association of Thailand 87(9): 1087-1091
Nesvold, A.; Kontny, F.; Abildgaard, U.; Dale, J. 1991: Safety of high doses of low molecular weight heparin (Fragmin) in acute myocardial infarction. a dose-finding study Thrombosis Research 64(5): 579-587
Costache, I.l.; Rusu, C.; Ivanov, I.; Popescu, R.; Petriş, A. 2012: Clopidogrel resistance--risk factor in patients with acute coronary syndromes Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 116(2): 383-388
Kłosiewicz-Latoszek, L.; Respondek, W.; Białobrzeska-Paluszkiewicz, J.; Grzybowska, B.; Jakóbisiak-Ostasz, B.; Stolarska, I. 2003: Efficacy and safety of combined statin-fenofibrates therapy compared with monotherapy in patients with mixed hyperlipidemia and high risk of coronary heart disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 15(85): 42-46
Madhavan, M.V.; Généreux, P.; Palmerini, T.; Caixeta, A.; Xu, K.; McAndrew, T.C.; Francese, D.P.; Kirtane, A.J.; Mehran, R.; Stone, G.W. 2015: The association between the extent of coronary artery disease and major bleeding events after percutaneous coronary intervention: from the ACUITY trial Journal of Invasive Cardiology 27(4): 203-211
Tungsubutra, W.; Tresukosol, D.; Krittayaphong, R.; Panchavinnin, P.; Phankingtongkhum, R.; Chotnaiwattarakul, C. 2007: Primary percutaneous transluminal coronary intervention compared with intravenous thrombolysis in patients with ST segment elevation myocardial infarction Journal of the Medical Association of Thailand 90(4): 672-678